...
首页> 外文期刊>Expert Review of Molecular Diagnostics >miRNA control of apoptotic programs: focus on ovarian cancer.
【24h】

miRNA control of apoptotic programs: focus on ovarian cancer.

机译:miRNA控制凋亡程序:专注于卵巢癌。

获取原文
获取原文并翻译 | 示例

摘要

miRNAs are a class of small non-coding RNAs that regulate the stability or translational efficiency of targeted mRNAs. miRNAs are involved in many cellular processes, such as differentiation, proliferation and apoptosis, which are altered in cancer through miRNA expression dysregulation. In this article we will discuss recent findings implicating miRNAs in apoptotic program regulation using ovarian carcinoma as an example. Ovarian cancer is the most lethal gynecological malignancy. Most patients are diagnosed with advanced disease that is conventionally managed with surgical resection followed by platinum-based chemotherapy. Killing of cancer cells by chemotherapeutic agents or by triggering cell-surface death receptors relies on activation of apoptotic programs executed through receptor-mediated extrinsic pathways and mitochondrial-dependent intrinsic pathways. Despite an initial good response to chemotherapy, ovarian cancer patients typically experience disease relapse within 2 years of the initial treatment developing resistance even to structurally different drugs. Thus, also in this pathology, tumor cells are able to evade apoptosis using multiple mechanisms, several of which are dependent on miRNA gene regulation.
机译:miRNA是一类小的非编码RNA,可调节目标mRNA的稳定性或翻译效率。 miRNA参与许多细胞过程,例如分化,增殖和凋亡,这些过程在癌症中会因miRNA表达失调而改变。在本文中,我们将讨论以卵巢癌为例,涉及miRNA参与凋亡程序调控的最新发现。卵巢癌是最致命的妇科恶性肿瘤。大多数患者被诊断为晚期疾病,通常通过外科手术切除,然后进行铂类化学疗法进行治疗。通过化学治疗剂或通过触发细胞表面死亡受体杀死癌细胞取决于通过受体介导的外在途径和线粒体依赖性内在途径执行的凋亡程序的激活。尽管对化学疗法最初有良好的反应,但卵巢癌患者通常会在初始治疗后2年内出现疾病复发,即使对结构不同的药物也产生耐药性。因此,同样在这种病理学中,肿瘤细胞能够使用多种机制逃避凋亡,其中一些机制依赖于miRNA基因调控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号